Indian astronaut Shubhanshu Shukla is part of the Ax-4 mission studying diabetes in space. This research could transform ...

Houston’s Axiom Space launched its fourth human spaceflight mission on Wednesday. One of the mission’s experiments hopes to ...

Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...

Discover how the Axiom-4 mission to the ISS is revolutionizing diabetes treatment with groundbreaking research on glucose ...

During their 14-day stay aboard the orbital lab, some astronauts on the Axiom-4 mission will be wearing continuous glucose ...

Axiom-4 astronauts are set to study insulin behaviour in microgravity, potentially transforming diabetes treatment and aiding ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

US pharma giant Eli Lilly has secured Indian regulatory approval to market Mounjaro, its widely used diabetes and weight-loss ...

The market is driven by rising diabetes prevalence worldwide and increasing adoption of wearable and connected devices ...

Explore how real-world evidence and biosimilars enhance insulin access and adherence, improving diabetes care and outcomes ...